Aurora Investment Counsel’s Fulgent Genetics FLGT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-8,312
Closed -$222K 116
2023
Q3
$222K Sell
8,312
-1,191
-13% -$40.7K 0.15% 113
2023
Q2
$352K Sell
9,503
-238
-2% -$8.3K 0.23% 115
2023
Q1
$304K Sell
9,741
-1,370
-12% -$44.1K 0.2% 111
2022
Q4
$331K Sell
11,111
-9,245
-45% -$331K 0.23% 112
2022
Q3
$776K Buy
20,356
+251
+1% +$12.6K 0.59% 96
2022
Q2
$1.1M Buy
20,105
+801
+4% +$44K 0.79% 66
2022
Q1
$1.21M Buy
19,304
+4,189
+28% +$276K 0.77% 69
2021
Q4
$1.52M Buy
15,115
+1,112
+8% +$97.7K 0.9% 48
2021
Q3
$1.26M Buy
+14,003
New +$1.27M 0.88% 50

Other funds holding FLGT

Aurora Investment Counsel's FLGT Position: Q4 2023 in Review

Aurora Investment Counsel sold out of Fulgent Genetics (FLGT) in Q4 2023, closing a stake of 8,312 shares — an estimated $222K sold.

Aurora Investment Counsel first reported a position in FLGT in Q3 2021 and held it in 9 quarters. The position peaked at $1.52M in Q4 2021. 196 funds tracked by Wall St. Rank hold FLGT as of Q4 2023.

  • Aurora Investment Counsel reported no remaining Fulgent Genetics position as of Q4 2023 after selling out during the quarter.
  • Aurora Investment Counsel sold 8,312 Fulgent Genetics shares in Q4 2023, an estimated $222K.
  • Aurora Investment Counsel first reported a position in Fulgent Genetics in Q3 2021 and held it in 9 quarters.
  • Aurora Investment Counsel's Fulgent Genetics position peaked at $1.52M in Q4 2021.
  • 196 funds tracked by Wall St. Rank held Fulgent Genetics as of Q4 2023.

Based on Aurora Investment Counsel's 13F filing for Q4 2023, filed 20 Feb 2024.